
Zach Reitano - Building Ro and Why Healthcare Should Be 50% of GDP - [Invest Like the Best, EP.500]
Invest Like the Best with Patrick O'Shaughnessy
- 1h 17m
- Transcript
Summary
Written by a model from the transcript; not yet reviewed.
This episode features a detailed conversation about the structure of the American healthcare system, the rise of GLP-1 medications, and the journey of refounding the direct-to-consumer digital health company Ro. The guest explains why the patient is rarely the customer in traditional healthcare and how direct-to-consumer models bypass costly intermediaries like pharmacy benefit managers. The discussion covers the dramatic turnaround of Ro in 2022, transitioning from a bloated organization to a leaner, highly focused team that scaled the business significantly while reducing headcount. The conversation also explores broader societal impacts of treating chronic illnesses upstream and the power of strong-attract, strong-repel company cultures.
- Healthcare systems often fail patients because the end consumer of care is rarely the one controlling the flow of money at the point of purchase. 6:16
- Eliminating unnecessary intermediaries like pharmacy benefit managers can dramatically reduce prescription drug prices while maintaining manufacturer profitability. 7:08
- Focusing on sequential execution rather than parallel projects prevents context switching and compounds organizational speed. 40:04
- Building a resilient company culture requires defining clear principles and embracing a strong-attract, strong-repel philosophy. 32:18
Chapters
- 0:00Podcast Intro and Sponsor Ads
The episode opens with sponsor advertisements and a brief introduction before the host begins the interview.
- 1:48Question on Healthcare GDP Share
The host asks the guest about the future percentage of GDP that healthcare should occupy.
- 4:00State of the U.S. Healthcare System
The guest provides a detailed breakdown of spending, outcomes, and the mismatch of incentives in the current system.
- 5:48Surprising Flaws in the System
The guest identifies the central flaw of patients not being customers and discusses how this misalignment drives inefficiencies.
- 6:58The Rise of GLP‑1s and Patient‑Centric Care
The guest describes how GLP‑1 drugs are reshaping care, lowering costs, and empowering patients to choose providers.
- 12:00Ro’s Business Model and Differentiation
The guest outlines Ro’s vertically integrated platform, its focus on patient experience, and its competitive advantages over pharma and direct services.
- 16:45Growth Trajectory and Market Impact
The guest discusses Ro’s rapid revenue growth, the expanding GLP‑1 market, and predictions for widespread adoption.
- 26:33Closing Reflections on Healthcare and Innovation
The guest concludes with thoughts on prioritizing outcomes over inputs, the societal impact of health tech, and the future of healthcare.
- 29:27Culture Reset and Refounding Story
The guest recounts the company’s near‑collapse, the decision to refound, and the implementation of a strong attract/strong repel culture.
- 36:46Leadership Lessons and Talent Focus
The guest shares insights on hiring, retaining top talent, and maintaining intense focus to drive sustained growth.
- 42:57Podcast Intro and Host Greeting
Patrick O'Shaughnessy opens the episode, introducing the guest and setting the stage for the discussion.
- 44:14Tailwinds Driving the Patient Revolution
Three key tailwinds—biological data, AI, and accessible treatments—are identified as catalysts for a new era of patient‑centric care.
Highlights
- 1:55
Healthcare Spending and Jevon's Paradoxinsight
The guest argues that healthcare should ideally consume a much larger percentage of GDP because healthy years have no diminishing marginal return, comparing healthcare growth to Jevon's paradox.
- 6:16
The Root Flaw of Healthcareinsight
The guest identifies the fundamental flaw of the US healthcare system: the patient is not the customer because out-of-pocket expenses represent a minority of total healthcare costs.
- 6:58
Cash Pay Success in Surgeryinsight
Cash-pay markets like Lasik and cosmetic surgeries demonstrate that when the patient is the customer, costs decrease while quality and convenience improve.
- 29:33
The guest details the painful realization in December 2021 that Ro had become a slow-growing zombie company, leading to a hard reset, leadership changes, and a 20 percent workforce reduction.
- 41:17
Daily Leadership Alignmentstrategy
To dramatically increase execution speed, the company instituted a mandatory daily 8:15 AM steering committee meeting that ran every single day for two straight years.
- 52:30
A Genetic Blueprint for Heart Diseasedata
A study on individuals with a faulty PCSK9 gene revealed an 85 to 90 percent reduction in heart disease risk, inspiring targeted oral and injectable therapies like Repatha.
Quotes
“I think it should be as high as possible, 57%.”
Unnamed speaker · 1:55 “The patient is not the customer.”
Unnamed speaker · 6:16 “I think we are at the beginning of this patient revolution.”
Unnamed speaker · 44:11 “Third is there are now treatments that do radically shift the quality and quantity of people's lives.”
Unnamed speaker · 45:14 “The side effect profile for me is incredibly favorable and it's a couple hundred dollars a month.”
Unnamed speaker · 51:09 “That's unbelievable. But it took us six years from genetic testing to discovering this faulty gene.”
Unnamed speaker · 53:18
Sponsored segments
- Ramp 59:15–59:32
- Vanta 59:26–59:44
- RidgeLine 59:36–59:53
- Rogo 59:53–1:00:08
- WorkOS 1:00:08–1:00:21
- Colossus 1:15:33–1:15:52
- Positive Sum 1:15:54–1:16:18
- Colossus 1:16:01–1:16:09
- Ramp 1:16:46–1:16:59
- Vanta 1:16:53–1:17:05
- WorkOS 1:17:05–1:17:13
- RidgeLine 1:17:13–1:17:27
- Rogo 1:17:24–1:17:40
About this episode
My guest today is Zach Reitano, the co-founder and CEO of Ro, the country’s leading provider of GLP-1s. In four years, Ro has grown from a $250 million run rate to over $3 billion, with fewer people than it had in 2021. The heart of our conversation is what he sees as the central flaw in American healthcare, which is that the patient is not the customer. He points to GLP-1s and LASIK as examples of what’s possible when patients pay directly, and he thinks AI could bring healthcare down to the price of a Netflix subscription. But to capture that opportunity, Zach first had to rebuild Ro's culture around high performance and a big heart. It shows in the stories Ro shares from people like Serena Williams, which help patients get past the stigma of seeking treatment. The inspiration behind it all is his father, a doctor whose care Zach wants to recreate in software. Please enjoy my conversation with Zach Reitano. For the full show notes, transcript, and links to mentioned content, check out the episode page here. ----- Become a Colossus member to get our quarterly print magazine and private audio experience, including exclusive profiles and early access to select episodes. Subscribe at colossus.com/subscribe. ----- Ramp’s mission is to help companies manage their spend in a way that reduces expenses and frees up time for teams to work on more valuable projects. Go to ramp.com/invest to sign up for free and get a $250 welcome bonus. ----- Trusted by thousands of businesses, Vanta continuously monitors your security posture and streamlines audits so you can win enterprise deals and build customer trust without the traditional overhead. Invest Like the Best listeners get a special offer of $1,000 off Vanta when you go to vanta.com/invest. ----- WorkOS is the infrastructure B2B and AI-native companies use to sell to enterprise. It covers everything enterprise security requires: SSO, SCIM, RBAC, Audit Logs, AI governance, and more. Trusted by 2,000+ fast-growing companies, including OpenAI, Anthropic, Cursor, and Vercel. ----- Rogo is the AI platform for finance. They're building agents for Wall Street that are trained to understand how bankers and investors actually do work: from diligence and modeling, to turning analysis into deliverables. To learn more, visit rogo.ai/invest. ----- Ridgeline has built a complete, real-time, modern operating system for investment managers. It handles trading, portfolio management, compliance, customer reporting, and much more through an all-in-one real-time cloud platform. Visit ridgeline.ai. ----- Editing and post-production work for this episode was provided by The Podcast Consultant. Timestamps: (00:01:35) Why Healthcare Spending Should Rise (00:05:39) Putting Patients in Control (00:10:37) Inside Ro's GLP-1 Business (00:16:29) How GLP-1s Could Reshape Society (00:23:15) The Hidden Cost of Protecting Jobs (00:28:35) Rebuilding a Zombie Company (00:36:33) What Drove Ro's 10x Growth (00:43:49) Where Healthcare Goes Next (00:46:27) Zach's Personal Health Stack (00:54:07) Finding the Work You Were Born For (01:00:15) Ro's Consumer Playbook (01:04:39) Breaking Medical Taboos (01:12:54) The Kindest Thing
Transcript
15,974 words · 3 speakers
Topics
- Row
- GLP-1
- Repatha
- PCSK9
- OpenAI
- Cursor
- Perplexity
Page updated · transcript and summary are machine-generated